• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

LumiThera

LumiThera closes second Series C financing round

January 13, 2020 By Sean Whooley

LumiThera announced today that it closed the second tranche of its Series C financing round with more than $10 million raised. The photobiomodulation (PBM) treatment developer earmarked the proceeds from the funding round for further clinical testing and commercialization of its Valeda light delivery system for treating dry age-related macular degeneration (AMD). LumiThera’s Valeda system […]

Filed Under: Business/Financial News, Clinical Trials, Funding Roundup, Optical/Ophthalmic Tagged With: LumiThera, Nikon, Optos Inc.

LumiThera inks Italian Valeda distro deal

December 11, 2018 By Fink Densford

LumiThera said today that it inked a deal with ophthalmology distributor Miloftalmica to be the exclusive distributor of the Valeda light delivery system, intended to treat dry age-related macular degeneration, across Italy. Therapy using the Valeda light delivery system consists of a series of light-based treatments to the retinal cells, which Seattle-based LumiThera claims improves […]

Filed Under: Business/Financial News, Distribution, Optical/Ophthalmic Tagged With: LumiThera

LumiThera inks distro deal with Nikon’s Optos

October 24, 2018 By Fink Densford

LumiThera said today it inked a distribution deal with Nikon (TYO:7731) subsidiary Optos to distribute its Valeda light delivery system intended for use in treating dry age-related macular degeneration. The deal will position Optos as the exclusive distributor of the device in 12 European countries, the Seattle-based company said. The device has already won CE Mark approval in the […]

Filed Under: Business/Financial News, Distribution, Optical/Ophthalmic Tagged With: LumiThera, Nikon, Optos Inc.

5 medtech stories we missed this week: July 6, 2018

July 6, 2018 By Danielle Kirsh

From Zetta getting FDA clearance to Prescient Medical receiving CE Mark approval, here are five medtech stories we missed this week but thought were still worth mentioning. 1. Zetta wins FDA clearance for Zoom MRI software Zetta announced in a June 25 press release that its MRI software has received FDA 510(k) clearance. The software, known […]

Filed Under: Diagnostics, Food & Drug Administration (FDA), Hospital Care, Imaging, Implants, Patient Monitoring, Surgical Tagged With: LumiThera, MedTech, MIM Software, Prescient Surgical, RTI Surgical, Spectrum Dynamics, Zetta

LumiThera touts interim data from pilot study of LT-300 AMD treatment

November 7, 2017 By Fink Densford

LumiThera today announced topline interim results from the Lightsite 1 trial of its LT-300 photobiomodulation device designed to treat dry age-related macular degeneration, touting statistically significant vision benefits maintained to 3 months. Data came from the 30-patient pilot study of the device, funded by a Small Business Innovation Research grant from the National Institute of Health […]

Filed Under: Clinical Trials, Optical/Ophthalmic Tagged With: LumiThera

LumiThera raises $6m in Series B

October 31, 2017 By Fink Densford

LumiThera said today it raised $5.5 million in a Series B round of financing to support the development of its LT-300 device designed for treating dry age-related macular degeneration. Proceeds from the round will support pursuit of regulatory clearance for the LT-300 device outside the US, including CE Mark approval in the European Union and additional […]

Filed Under: Business/Financial News Tagged With: LumiThera

LumiThera wins Health Canada nod for photobiomodulation trial

March 24, 2016 By Fink Densford

LumiThera said today it won Health Canada approval for its Lightsite clinical trial examining the effect of its non-invasive photobiomodulation treatment in patients with age-related macular degeneration. The Seattle-based company’s study is being sponsored by a grant from the National Institute of Health and the division of the National Eye Institute. “The design of the study […]

Filed Under: Clinical Trials, Optical/Ophthalmic, Regulatory/Compliance Tagged With: LumiThera

Biolase lures Zimmer Dental prez Flynn for CEO role | Personnel Moves

May 20, 2015 By Brad Perriello

Biolase lures Zimmer Dental prez Flynn for CEO role | Personnel Moves

Filed Under: News Well Tagged With: Abbott, Alphabet (Google), Bellerophon Therapeutics, Biolase, Bioventus LLC, iRhythm Technologies Inc., LumiThera, NxStage Medical Inc., Personnel Moves, Reva Medical Inc., Sorin Group, Xeltis, Zimmer Biomet

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS